Literature DB >> 363940

Restricted complement activation by Escherichia coli with the K-1 capsular serotype: a possible role in pathogenicity.

P Stevens, S N Huang, W D Welch, L S Young.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 363940

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  24 in total

Review 1.  Escherichia coli in extra-intestinal infections.

Authors:  I Orskov; F Orskov
Journal:  J Hyg (Lond)       Date:  1985-12

2.  Quantitation of the third component of human complement attached to the surface of opsonized bacteria: opsonin-deficient sera and phagocytosis-resistant strains.

Authors:  H A Verbrugh; W C van Dijk; M E van Erne; R Peters; P K Peterson; J Verhoef
Journal:  Infect Immun       Date:  1979-12       Impact factor: 3.441

Review 3.  Modulation of phagocytic cell function.

Authors:  P A Henricks; J Verhoef; F P Nijkamp
Journal:  Vet Res Commun       Date:  1986-05       Impact factor: 2.459

Review 4.  Complement resistance in microbes.

Authors:  M C Moffitt; M M Frank
Journal:  Springer Semin Immunopathol       Date:  1994

5.  TraJ-dependent Escherichia coli K1 interactions with professional phagocytes are important for early systemic dissemination of infection in the neonatal rat.

Authors:  Val T Hill; Stacy M Townsend; Robyn S Arias; Jasmine M Jenabi; Ignacio Gomez-Gonzalez; Hiroyuki Shimada; Julie L Badger
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

6.  Comparison of loss of serum resistance by defined lipopolysaccharide mutants and an acapsular mutant of uropathogenic Escherichia coli O75:K5.

Authors:  S M Burns; S I Hull
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

7.  Aerobactin iron transport genes commonly encoded by certain ColV plasmids occur in the chromosome of a human invasive strain of Escherichia coli K1.

Authors:  M A Valvano; J H Crosa
Journal:  Infect Immun       Date:  1984-10       Impact factor: 3.441

8.  Differential complement resistance mediates virulence of Haemophilus influenzae type b.

Authors:  A Sutton; R Schneerson; S Kendall-Morris; J B Robbins
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

9.  Antibodies to O-antigen of lipopolysaccharide are protective against neonatal infection with Escherichia coli K1.

Authors:  G Pluschke; M Achtman
Journal:  Infect Immun       Date:  1985-08       Impact factor: 3.441

10.  Effect of immune serum or polymyxin B on Escherichia coli-induced inflammation and vascular injury.

Authors:  A C Issekutz; S Bhimji; R Bortolussi
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.